Literature DB >> 32992177

Mobile App Based Strategy Improves Door-to-Needle Time in the Treatment of Acute Ischemic Stroke.

Mohan Leslie Noone1, Fabith Moideen2, Reshma B Krishna3, V G Pradeep Kumar4, Ummer Karadan5, Jayakrishnan Chellenton6, K A Salam7.   

Abstract

BACKGROUND: Time to revascularization is critical in improving outcomes in stroke thrombolysis. We studied the effectiveness of a mobile app based strategy to improve door-to-needle time (DNT) in treatment of acute ischemic stroke.
METHODS: Consecutive patients presenting with acute ischemic stroke to the emergency department at a tertiary care hospital in Southern India between April 2017 - September 2018 were included. The app enabled rapid entry of patient parameters, the NIH stroke scale (NIHSS), thrombolysis checklist and dose calculation along with team synchronization, notifying all on-call members and team leaders of the patient movement, and sharing of radiological images. DNT captured from the app was compared to previous values from our center using one-way Analysis of Variance (ANOVA) after adjusting for differences in baseline variables.
RESULTS: A total of 76 patients were thrombolysed during the study period, while using the mobile app. The mean DNT was 41 min, with 89% being thrombolysed within 60 min and 57% being thrombolysed within 45 min. Compared to 100 consecutive patients thrombolysed in the months prior to April 2017 where the mean DNT was 57 min, with 67% thrombolysed within 60 min and 47% being thrombolysed within 45 min, there was a mean DNT decrease of 16 min with 1.3x increase in DNT < 60 min. This difference was statistically significant after adjusting for age, sex and NIHSS Score (p=0.005, One-Way ANOVA).
CONCLUSION: We have been able to demonstrate a significant improvement in DNT using mobile app as a tool to improve team performance.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebral infarction; Door-to-needle time; Mobile application; Thrombolysis

Mesh:

Substances:

Year:  2020        PMID: 32992177     DOI: 10.1016/j.jstrokecerebrovasdis.2020.105319

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  5 in total

Review 1.  Smartphone App in Stroke Management: A Narrative Updated Review.

Authors:  Adriano Bonura; Francesco Motolese; Fioravante Capone; Gianmarco Iaccarino; Michele Alessiani; Mario Ferrante; Rosalinda Calandrelli; Vincenzo Di Lazzaro; Fabio Pilato
Journal:  J Stroke       Date:  2022-09-30       Impact factor: 8.632

2.  Prehospital Notification Using a Mobile Application Can Improve Regional Stroke Care System in a Metropolitan Area.

Authors:  Sang-Hun Lee; Hyun Wook Ryoo; Sang-Chan Jin; Jae Yun Ahn; Sung-Il Sohn; Yang-Ha Hwang; Youngrok Do; Yoon-Soo Lee; Jung Ho Kim
Journal:  J Korean Med Sci       Date:  2021-12-13       Impact factor: 2.153

3.  Advancement of door-to-needle times in acute stroke treatment after repetitive process analysis: never give up!

Authors:  Johanna Ernst; Kai F Storch; Anh Thu Tran; Maria M Gabriel; Andrei Leotescu; Anna-Lena Boeck; Meret K Huber; Omar Abu-Fares; Paul Bronzlik; Friedrich Götz; Hans Worthmann; Ramona Schuppner; Gerrit M Grosse; Karin Weissenborn
Journal:  Ther Adv Neurol Disord       Date:  2022-09-15       Impact factor: 6.430

Review 4.  How to Improve the Management of Acute Ischemic Stroke by Modern Technologies, Artificial Intelligence, and New Treatment Methods.

Authors:  Kamil Zeleňák; Antonín Krajina; Lukas Meyer; Jens Fiehler; Daniel Behme; Deniz Bulja; Jildaz Caroff; Amar Ajay Chotai; Valerio Da Ros; Jean-Christophe Gentric; Jeremy Hofmeister; Omar Kass-Hout; Özcan Kocatürk; Jeremy Lynch; Ernesto Pearson; Ivan Vukasinovic
Journal:  Life (Basel)       Date:  2021-05-27

5.  Effectiveness of a Mobile App in Reducing Therapeutic Turnaround Time and Facilitating Communication between Caregivers in a Pediatric Emergency Department: A Randomized Controlled Pilot Trial.

Authors:  Frederic Ehrler; Carlotta Tuor; Remy Trompier; Antoine Berger; Michael Ramusi; Robin Rey; Johan N Siebert
Journal:  J Pers Med       Date:  2022-03-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.